LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 34.50 | 770.25 | 1874 | 3712 | 0.5049 | 0.4798 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 36.73 | 770.25 | 2031 | 4086 | 0.4971 | 0.4959 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 36.73 | 770.25 | 1955 | 4086 | 0.4785 | 0.4724 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 38.95 | 770.25 | 2129 | 4543 | 0.4685 | 0.4875 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 38.95 | 770.25 | 2086 | 4543 | 0.4591 | 0.4757 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 41.17 | 770.25 | 2230 | 5010 | 0.4451 | 0.4821 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 41.17 | 770.25 | 2227 | 5010 | 0.4445 | 0.4814 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 43.39 | 770.25 | 2376 | 5404 | 0.4396 | 0.4930 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 43.39 | 770.25 | 2393 | 5404 | 0.4428 | 0.4968 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 45.61 | 770.25 | 2527 | 5813 | 0.4347 | 0.5030 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 45.61 | 770.25 | 2553 | 5813 | 0.4392 | 0.5083 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 47.83 | 770.25 | 2699 | 6223 | 0.4337 | 0.5159 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 47.83 | 770.25 | 2704 | 6223 | 0.4345 | 0.5168 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 50.05 | 770.25 | 2907 | 6629 | 0.4385 | 0.5337 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 50.05 | 770.25 | 2908 | 6629 | 0.4387 | 0.5339 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 52.27 | 770.25 | 3072 | 7058 | 0.4352 | 0.5416 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 52.27 | 770.25 | 3132 | 7058 | 0.4437 | 0.5510 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 54.49 | 770.25 | 3269 | 7555 | 0.4327 | 0.5509 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 54.49 | 770.25 | 3362 | 7555 | 0.4450 | 0.5641 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 56.71 | 770.25 | 3418 | 8001 | 0.4272 | 0.5547 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 56.71 | 770.25 | 3537 | 8001 | 0.4420 | 0.5705 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 58.94 | 770.25 | 3560 | 8444 | 0.4216 | 0.5576 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 58.94 | 770.25 | 3762 | 8444 | 0.4455 | 0.5826 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 61.16 | 770.25 | 3667 | 8892 | 0.4124 | 0.5561 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 61.16 | 770.25 | 3901 | 8892 | 0.4387 | 0.5836 | MN20160304_L02 | F12 |